Skip to content
2000
Volume 19, Issue 3
  • ISSN: 2772-2708
  • E-ISSN: 2772-2716

Abstract

Chrysophanol, a naturally occurring anthraquinone compound found in various plants, fungi, and lichens, has garnered increasing attention for its potential therapeutic benefits, particularly in the context of inflammation-related disorders. This review aims to provide a comprehensive overview of the anti-inflammatory properties of chrysophanol and its potential as a therapeutic agent for intervention in inflammatory conditions. In this review, the current understanding of the molecular mechanisms underlying the anti-inflammatory effects of Chrysophanol, including its modulation of key inflammatory signaling pathways, such as NF-κB, MAPK, JAK-STAT, Nrf2, and other NLRP3 inflammasomes. Additionally, we discuss the evidence from and studies supporting the anti-inflammatory efficacy of chrysophanol in various experimental models of inflammation, including various inflammatory diseases. Furthermore, we explore the pharmacokinetic profile of Chrysophanol and other nanoformulations to understand its therapeutic potential. Overall, accumulating evidence suggests that chrysophanol holds promise as a novel therapeutic candidate for the management of inflammatory disorders, warranting further investigation and clinical translation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raiad/10.2174/0127722708325360240925043542
2024-10-04
2026-02-28

  • From This Site

    /content/journals/raiad/10.2174/0127722708325360240925043542
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. DeviS. ChauhanS. MannanA. SinghT.G. Targeting cardiovascular risk factors with eugenol: An anti-inflammatory perspective.Inflammopharmacology20232023111 38085446
     [Google Scholar]
  2. Schmid-SchönbeinG.W. Analysis of inflammation.Annu. Rev. Biomed. Eng.2006819315110.1146/annurev.bioeng.8.061505.095708 16834553
     [Google Scholar]
  3. Bashir DarK. Hussain BhatA. AminS. MasoodA. Afzal ZargarM. Ahmad GanieS. Inflammation: A multidimensional insight on natural anti-inflammatory therapeutic compounds.Curr. Med. Chem.201623333775380010.2174/0929867323666160817163531 27538691
     [Google Scholar]
  4. YeungY.T. AzizF. Guerrero-CastillaA. ArguellesS. Signaling pathways in inflammation and anti-inflammatory therapies.Curr. Pharm. Des.201824141449148410.2174/1381612824666180327165604 29589535
     [Google Scholar]
  5. AttiqA. JalilJ. HusainK. AhmadW. Raging the war against inflammation with natural products.Front. Pharmacol.2018997610.3389/fphar.2018.00976 30245627
     [Google Scholar]
  6. YuanH. MaQ. YeL. PiaoG. The traditional medicine and modern medicine from natural products.Molecules201621555910.3390/molecules21050559 27136524
     [Google Scholar]
  7. Van Der ZandenE.P. BoeckxstaensG.E. De JongeW.J. The vagus nerve as a modulator of intestinal inflammation.Neurogastroenterol. Motil.200921161710.1111/j.1365‑2982.2008.01252.x 19140954
     [Google Scholar]
  8. ChenL. DengH. CuiH. Inflammatory responses and inflammation-associated diseases in organs.Oncotarget2018967204721810.18632/oncotarget.23208 29467962
     [Google Scholar]
  9. Prateeksha YusufM.A. SinghB.N. Chrysophanol: A natural anthraquinone with multifaceted biotherapeutic potential.Biomolecules2019926810.3390/biom9020068 30781696
     [Google Scholar]
  10. LinC.N. ChungM.I. LuC.M. Anthraquinones from Rhamnus formosana.Phytochemistry199029123903390510.1016/0031‑9422(90)85356‑K
     [Google Scholar]
  11. TruzziF. TibaldiC. ZhangY. DinelliG. D Amen E. An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS).Int. J. Mol. Sci.20212211551410.3390/ijms22115514 34073709
     [Google Scholar]
  12. WangS. ZhangJ. YanC. HouY. XueG. ZhangL. Chrysophanol attenuates lead exposure-induced injury to hippocampal neurons in neonatal mice.Neural Regen. Res.20149992493010.4103/1673‑5374.133141 25206913
     [Google Scholar]
  13. ChenQ. HeH. XiongL. LiP. LiP. A novel GC–MS method for determination of chrysophanol in rat plasma and tissues: Application to the pharmacokinetics, tissue distribution and plasma protein binding studies.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2014973768310.1016/j.jchromb.2014.10.011 25464098
     [Google Scholar]
  14. LiuX. LiH. WuL. Simultaneous quantification of chrysophanol and physcion in rat plasma by ultra fast liquid chromatography–tandem mass spectrometry and application of the technique to comparative pharmacokinetic studies of Radix et Rhei Rhizoma extract alone and Dahuang Fuzi Decoction.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2015980889310.1016/j.jchromb.2014.11.025 25597888
     [Google Scholar]
  15. QianZ.J. ZhangC. LiY.X. JeJ.Y. KimS.K. JungW.K. Protective Effects of Emodin and Chrysophanol Isolated from Marine Fungus Aspergillus sp. on Ethanol‐Induced Toxicity in HepG2/CYP2E1 Cells.Evid. Based Complement. Alternat. Med.20112011145262110.1155/2011/452621 21912566
     [Google Scholar]
  16. XieL. TangH. SongJ. LongJ. ZhangL. LiX. Chrysophanol: A review of its pharmacology, toxicity and pharmacokinetics.J. Pharm. Pharmacol.201971101475148710.1111/jphp.13143 31373015
     [Google Scholar]
  17. SuS. WuJ. GaoY. LuoY. YangD. WangP. The pharmacological properties of chrysophanol, the recent advances.Biomed. Pharmacother.202012511000210.1016/j.biopha.2020.110002 32066044
     [Google Scholar]
  18. KanyS. VollrathJ.T. ReljaB. Cytokines in inflammatory disease.Int. J. Mol. Sci.20192023600810.3390/ijms20236008 31795299
     [Google Scholar]
  19. AodahA.H. DeviS. AlkholifiF.K. YusufogluH.S. FoudahA.I. AlamA. Effects of Taraxerol on Oxidative and Inflammatory Mediators in Isoproterenol-Induced Cardiotoxicity in an Animal Model.Molecules20232810408910.3390/molecules28104089 37241830
     [Google Scholar]
  20. LuL. LiK. MaoY.H. Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.Int. J. Oncol.20175141089110310.3892/ijo.2017.4095 28849003
     [Google Scholar]
  21. AlkholifiF.K. DeviS. AldawsariM.F. Effects of Tiliroside and Lisuride Co-Treatment on the PI3K/Akt Signal Pathway: Modulating Neuroinflammation and Apoptosis in Parkinson’s Disease.Biomedicines20231110273510.3390/biomedicines11102735 37893109
     [Google Scholar]
  22. ZhaoY. FangY. LiJ. Neuroprotective effects of Chrysophanol against inflammation in middle cerebral artery occlusion mice.Neurosci. Lett.2016630162210.1016/j.neulet.2016.07.036 27450437
     [Google Scholar]
  23. TanJ. YadavM.K. DeviS. KumarM. Neuroprotective effects of arbutin against oxygen and glucose deprivation-induced oxidative stress and neuroinflammation in rat cortical neurons.Acta Pharm.202272112313410.2478/acph‑2022‑0002 36651531
     [Google Scholar]
  24. FoudahA.I. DeviS. AlamA. SalkiniM.A. RossS.A. Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer’s disease in rats: Mechanistic approach to prevent inflammation.Front. Pharmacol.202314111572110.3389/fphar.2023.1115721 36817151
     [Google Scholar]
  25. AlharthyK. BalahaM. DeviS. Ameliorative Effects of Isoeugenol and Eugenol against Impaired Nerve Function and Inflammatory and Oxidative Mediators in Diabetic Neuropathic Rats.Biomedicines2023114120310.3390/biomedicines11041203 37189822
     [Google Scholar]
  26. LiuT. ZhangL. JooD. SunS.C. NF-κB signaling in inflammation.Signal Transduct. Target. Ther.20172119
     [Google Scholar]
  27. BehlT. UpadhyayT. SinghS. Polyphenols targeting MAPK mediated oxidative stress and inflammation in rheumatoid arthritis.Molecules20212621657010.3390/molecules26216570 34770980
     [Google Scholar]
  28. CargnelloM. RouxP.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.Microbiol. Mol. Biol. Rev.2011751508310.1128/MMBR.00031‑10 21372320
     [Google Scholar]
  29. WenQ. LauN. WengH. Chrysophanol exerts anti-inflammatory activity by targeting histone deacetylase 3 through the high mobility group protein 1-nuclear transcription factor-kappa B signaling pathway in vivo and in vitro.Front. Bioeng. Biotechnol.2021862386610.3389/fbioe.2020.623866 33569375
     [Google Scholar]
  30. BanerjeeS. BiehlA. GadinaM. HasniS. SchwartzD.M. JAK–STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects.Drugs201777552154610.1007/s40265‑017‑0701‑9 28255960
     [Google Scholar]
  31. LeeH.S. JeongG.S. Chrysophanol attenuates manifestations of immune bowel diseases by regulation of colorectal cells and T cells activation in vivo.Molecules2021266168210.3390/molecules26061682 33802855
     [Google Scholar]
  32. PandayA. IndaM.E. BagamP. SahooM.K. OsorioD. BatraS. Transcription factor NF-κB: An update on intervention strategies.Arch. Immunol. Ther. Exp. (Warsz.)201664646348310.1007/s00005‑016‑0405‑y 27236331
     [Google Scholar]
  33. SelçukK.T. Epidemiology of inflammation-related diseases. Role of Nutrition in Providing Pro-/Anti-Inflammatory Balance: Emerging Research and Opportunities.Pennsylvania, United StatesIGI Global20202444
     [Google Scholar]
  34. WenQ. MeiL. YeS. Chrysophanol demonstrates anti-inflammatory properties in LPS-primed RAW 264.7 macrophages through activating PPAR-γ.Int. Immunopharmacol.201856909710.1016/j.intimp.2018.01.023 29367091
     [Google Scholar]
  35. ZhaoH. WangY. ZhuX. Chrysophanol exerts a protective effect against sepsis-induced acute myocardial injury through modulating the microRNA-27b-3p/Peroxisomal proliferating-activated receptor gamma axis.Bioengineered2022135126731269010.1080/21655979.2022.2063560 35599576
     [Google Scholar]
  36. NgG.Y.Q. LohZ.W.L. FannD.Y. MallilankaramanK. ArumugamT.V. HandeM.P. Role of Mitogen-Activated Protein (MAP) Kinase Pathways in Metabolic Diseases.Genome Integr.202415e2023000310.14293/genint.14.1.004 38770527
     [Google Scholar]
  37. YoonS. SegerR. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions.Growth Factors2006241214410.1080/02699050500284218 16393692
     [Google Scholar]
  38. YadavP. ChauhanN.S. Modulatory role of plant-derived metabolites on host-microbiota interactions: Personalized therapeutics outlook.Biocell20244881127114310.32604/biocell.2024.051318
     [Google Scholar]
  39. LuJ. MiaoZ. JiangY. Chrysophanol prevents IL-1β-Induced inflammation and ECM degradation in osteoarthritis via the Sirt6/NF-κB and Nrf2/NF-κB axis.Biochem. Pharmacol.202320811540210.1016/j.bcp.2022.115402 36592706
     [Google Scholar]
  40. RawlingsJ.S. RoslerK.M. HarrisonD.A. The JAK/STAT signaling pathway.J. Cell Sci.200411781281128310.1242/jcs.00963 15020666
     [Google Scholar]
  41. PfitznerE. KliemS. BausD. LitterstC.M. The role of STATs in inflammation and inflammatory diseases.Curr. Pharm. Des.200410232839285010.2174/1381612043383638 15379672
     [Google Scholar]
  42. HuQ. BianQ. RongD. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens.Front. Bioeng. Biotechnol.202311111076510.3389/fbioe.2023.1110765 36911202
     [Google Scholar]
  43. ParkY.J. LeeK.H. JeonM.S. Hepatoprotective potency of chrysophanol 8-O-glucoside from Rheum palmatum L. against hepatic fibrosis via regulation of the STAT3 signaling pathway.Int. J. Mol. Sci.20202123904410.3390/ijms21239044 33261209
     [Google Scholar]
  44. SelimN.M. ElgazarA.A. Abdel-HamidN.M. Chrysophanol, physcion, hesperidin and curcumin modulate the gene expression of pro-inflammatory mediators induced by LPS in HepG2: In silico and molecular studies.Antioxidants20198937110.3390/antiox8090371 31484451
     [Google Scholar]
  45. SahaS. ButtariB. PanieriE. ProfumoE. SasoL. An overview of Nrf2 signaling pathway and its role in inflammation.Molecules20202522547410.3390/molecules25225474 33238435
     [Google Scholar]
  46. AhmedS.M.U. LuoL. NamaniA. WangX.J. TangX. Nrf2 signaling pathway: Pivotal roles in inflammation.Biochim. Biophys. Acta Mol. Basis Dis.201718632585597
     [Google Scholar]
  47. ZojaC. BenigniA. RemuzziG. The Nrf2 pathway in the progression of renal disease.Nephrol. Dial. Transplant.201429Suppl. 1i19i2410.1093/ndt/gft224 23761459
     [Google Scholar]
  48. Krajka-KuźniakV. PaluszczakJ. Baer-DubowskaW. The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment.Pharmacol. Rep.201769339340210.1016/j.pharep.2016.12.011 28267640
     [Google Scholar]
  49. LianY. XiaX. ZhaoH. ZhuY. The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice.Biomed. Pharmacother.2017931175118910.1016/j.biopha.2017.05.148 28738526
     [Google Scholar]
  50. HeY. HaraH. NúñezG. Mechanism and regulation of NLRP3 inflammasome activation.Trends Biochem. Sci.201641121012102110.1016/j.tibs.2016.09.002 27669650
     [Google Scholar]
  51. GroslambertM. PyB. Spotlight on the NLRP3 inflammasome pathway.J. Inflamm. Res.20181135937410.2147/JIR.S141220 30288079
     [Google Scholar]
  52. PaikS. KimJ.K. SilwalP. SasakawaC. JoE.K. An update on the regulatory mechanisms of NLRP3 inflammasome activation.Cell. Mol. Immunol.20211851141116010.1038/s41423‑021‑00670‑3 33850310
     [Google Scholar]
  53. DuezH. PourcetB. Nuclear receptors in the control of the NLRP3 inflammasome pathway.Front. Endocrinol. (Lausanne)20211263053610.3389/fendo.2021.630536 33716981
     [Google Scholar]
  54. PatelS. Danger-associated molecular patterns (DAMPs): The derivatives and triggers of inflammation.Curr. Allergy Asthma Rep.201818116310.1007/s11882‑018‑0817‑3 30267163
     [Google Scholar]
  55. KelleyN. JeltemaD. DuanY. HeY. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation.Int. J. Mol. Sci.20192013332810.3390/ijms20133328 31284572
     [Google Scholar]
  56. XiaP. MarjanM. LiuZ. Chrysophanol postconditioning attenuated cerebral ischemia-reperfusion injury induced NLRP3-related pyroptosis in a TRAF6-dependent manner.Exp. Neurol.202235711419710.1016/j.expneurol.2022.114197 35932799
     [Google Scholar]
  57. MaS. XuH. HuangW. Chrysophanol relieves cisplatin-induced nephrotoxicity via concomitant inhibition of oxidative stress, apoptosis, and inflammation.Front. Physiol.20211270635910.3389/fphys.2021.706359 34658905
     [Google Scholar]
  58. JeongH.J. KimH.Y. KimH.M. Molecular mechanisms of anti-inflammatory effect of chrysophanol, an active component of AST2017-01 on atopic dermatitis in vitro models.Int. Immunopharmacol.20185423824410.1016/j.intimp.2017.11.019 29161660
     [Google Scholar]
  59. KwonK.S. LeeJ.H. SoK.S. Aurantio‐obtusin, an anthraquinone from cassiae semen, ameliorates lung inflammatory responses.Phytother. Res.20183281537154510.1002/ptr.6082 29675883
     [Google Scholar]
  60. LinF. ZhangC. ChenX. Chrysophanol affords neuroprotection against microglial activation and free radical-mediated oxidative damage in BV2 murine microglia.Int. J. Clin. Exp. Med.20158334473455 26064235
     [Google Scholar]
  61. RimH.K. MoonP.D. ChoiI.H. LeeE.H. KimH.M. JeongH.J. SoSoSo or its active ingredient chrysophanol regulates production of inflammatory cytokines & adipokine in both macrophages & adipocytes.Indian J. Med. Res.20131371142150 23481064
     [Google Scholar]
  62. LiuX. ZhangX. ChenJ. Chrysophanol facilitates long-term neurological recovery through limiting microglia-mediated neuroinflammation after ischemic stroke in mice.Int. Immunopharmacol.202211210922010.1016/j.intimp.2022.109220 36095949
     [Google Scholar]
  63. KimS.J. KimM.C. LeeB.J. ParkD.H. HongS.H. UmJ.Y. Anti-Inflammatory activity of chrysophanol through the suppression of NF-kappaB/caspase-1 activation in vitro and in vivo.Molecules20101596436645110.3390/molecules15096436 20877234
     [Google Scholar]
  64. LiuC. XuX. HeX. Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease.Ann. Med.2023552228489010.1080/07853890.2023.2284890 38039549
     [Google Scholar]
  65. ChengS. ChenW. GuoZ. Paeonol alleviates ulcerative colitis by modulating PPAR-γ and nuclear factor-κB activation.Sci. Rep.20241411839010.1038/s41598‑024‑68992‑6 39117680
     [Google Scholar]
  66. HanN.R. KimH.Y. KangS. Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.Inflamm. Res.201968756957910.1007/s00011‑019‑01239‑7 31055607
     [Google Scholar]
  67. SongG. ZhangY. YuS. Chrysophanol attenuates airway inflammation and remodeling through nuclear factor‐kappa B signaling pathway in asthma.Phytother. Res.201933102702271310.1002/ptr.6444 31313371
     [Google Scholar]
  68. AlkabbaniM.A. ShatatA.A. GhazyA.N. MagdyK. CChemotherapy-Induced Liver Injury: Unveiling Emerging Mechanisms and Exploring Mitigation Strategies.ERU Res J202420241100
     [Google Scholar]
  69. ZengJ. BaoT. YangK. The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review.Front. Immunol.202313104755010.3389/fimmu.2022.1047550 36818470
     [Google Scholar]
  70. ZhangN. ZhangX. LiuX. Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice.Mediators Inflamm.2014201411210.1155/2014/370530 24876671
     [Google Scholar]
  71. CuongN.M. KhanhP.N. HuongT.T. In vitro and in silico inhibitory activity of angiotensin-converting enzyme ii and anti-inflammatory effects of natural compounds from rheum officinale roots.Vietnam J. Sci. Technol.202362418989
     [Google Scholar]
  72. RobertsJ.A. RainbowR.D. SharmaP. Mitigation of cardiovascular disease and toxicity through NRF2 signalling.Int. J. Mol. Sci.2023247672310.3390/ijms24076723 37047696
     [Google Scholar]
  73. HanN.R. MoonP.D. YooM.S. RyuK.J. KimH.M. JeongH.J. Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis.Int. Immunopharmacol.20186222022610.1016/j.intimp.2018.06.046 30025384
     [Google Scholar]
  74. ZhangK. LiuJ. YouX. P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice.Neurosci. Lett.2016613606510.1016/j.neulet.2015.12.043 26724370
     [Google Scholar]
  75. JiangW. ZhouR. LiP. Protective effect of chrysophanol on LPS/d -GalN-induced hepatic injury through the RIP140/NF-κB pathway.RSC Advances2016644381923820010.1039/C5RA19841K
     [Google Scholar]
  76. ZhangC. SongY. WangC. The effects of chrysophanol on ovalbumin (OVA)-induced chronic lung toxicology by inhibiting Th17 response.Toxicol. Mech. Methods201727532733410.3109/15376516.2015.1053653 28399782
     [Google Scholar]
  77. KimH.Y. JeeH. YeomJ.H. JeongH.J. KimH.M. The ameliorative effect of AST2017-01 in an ovalbumin-induced allergic rhinitis animal model.Inflamm. Res.201968538739510.1007/s00011‑019‑01226‑y 30874868
     [Google Scholar]
  78. LiA. LiuY. ZhaiL. WangL. LinZ. WangS. Activating peroxisome proliferator-activated receptors (PPARs): A new sight for chrysophanol to treat paraquat-induced lung injury.Inflammation201639292893710.1007/s10753‑016‑0326‑2 26920845
     [Google Scholar]
  79. ChuX. ZhouS. SunR. Chrysophanol relieves cognition deficits and neuronal loss through inhibition of inflammation in diabetic mice.Neurochem. Res.201843497298310.1007/s11064‑018‑2503‑1 29497904
     [Google Scholar]
  80. ZhangJ. KangH. WangL. ZhaoX. Chrysophanol ameliorates high-fat diet-induced obesity and inflammation in neonatal rats.Pharmazie2018734228233 29609691
     [Google Scholar]
  81. KeJ.Y. SongJ.B. LiL. Macrophage involvement in the pathological evolution of ulcerative colitis-associated colon cancer and progress of related traditional Chinese medicine drug interventions.Tra Med Res2023884610.53388/TMR20230228001
     [Google Scholar]
  82. Xiao-MeiY. Jun-ShengL. Guo-XiaH. Qi-QianL. Liu-JuanY. Study on potential toxic mechanism of chrysophanol binding DNA by saturation value binding DNA.Asian J. Chem.2012242551
     [Google Scholar]
  83. ShiaC.S. TsaiS.Y. LinJ.C. Steady-state pharmacokinetics and tissue distribution of anthraquinones of Rhei Rhizoma in rats.J. Ethnopharmacol.201113731388139410.1016/j.jep.2011.08.003 21855620
     [Google Scholar]
  84. KangL. SiL. RaoJ. Polygoni Multiflori Radix derived anthraquinones alter bile acid disposition in sandwich-cultured rat hepatocytes.Toxicol. In Vitro20174031332310.1016/j.tiv.2017.01.022 28161596
     [Google Scholar]
  85. PanigrahiG.K. ChR. MudiamM.K.R. VashishthaV.M. RaisuddinS. DasM. Activity-guided chemo toxic profiling of Cassia occidentalis (CO) seeds: Detection of toxic compounds in body fluids of CO-exposed patients and experimental rats.Chem. Res. Toxicol.20152861120113210.1021/acs.chemrestox.5b00056 25915165
     [Google Scholar]
  86. Kondeva-BurdinaM. SimeonovaR. VitchevaV. Effects of Asphodeline lutea compounds on toxicity models in isolated rat microsomes and hepatocytes.Lett. Drug Des. Discov.201815325125510.2174/1570180814666170306122707
     [Google Scholar]
  87. WaisU. JacksonA.W. HeT. ZhangH. Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles.Nanoscale2016841746176910.1039/C5NR07161E 26731460
     [Google Scholar]
  88. Smriti SinglaM. GuptaS Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route.Front. Pharmacol.202314121862510.3389/fphar.2023.1218625 37492081
     [Google Scholar]
  89. SinghS.K. ThakurK. SharmaV. Exploring the multifaceted potential of chlorogenic acid: Journey from nutraceutical to nanomedicine.S. Afr. J. Bot.202315965867710.1016/j.sajb.2023.06.038
     [Google Scholar]
  90. VarlıM. KimE. OhS. Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex.Cancer Cell Int.202424125310.1186/s12935‑024‑03434‑x 39030594
     [Google Scholar]
  91. SindhuR. AroraS. Anti-inflammatory potential of different extracts isolated from the roots of Ficus lacor buch. Hum and Murraya koenigii L. spreng.Arch. Biol. Sci.20146631261127010.2298/ABS1403261S
     [Google Scholar]
/content/journals/raiad/10.2174/0127722708325360240925043542
Loading
Chrysophanol: A Promising Agent in Modulating Inflammatory Pathways
Rec Adv Inflamm Allergy Drug Discov 19, 328 (2025); https://doi.org/10.2174/0127722708325360240925043542
/content/journals/raiad/10.2174/0127722708325360240925043542
/content/journals/raiad/10.2174/0127722708325360240925043542
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Chrysophanol; inflammation; JAK-STAT; MAPK; NF-κB; Nrf2 and NLRP3 inflammasome

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test